Come up with a name for your new list and we'll add to it:
Actagene Oncology was acquired by
Ignyta on May 21, 2013.
Actagene Oncology is a San Diego based privately held biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. In …